nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—Propranolol—migraine	0.408	1	CrCtD
Propafenone—Bevantolol—Verapamil—migraine	0.0833	0.324	CrCrCtD
Propafenone—Bopindolol—Propranolol—migraine	0.0486	0.189	CrCrCtD
Propafenone—Carvedilol—Propranolol—migraine	0.0443	0.172	CrCrCtD
Propafenone—Bevantolol—Propranolol—migraine	0.0377	0.147	CrCrCtD
Propafenone—Esmolol—Propranolol—migraine	0.0279	0.109	CrCrCtD
Propafenone—ADRB1—Timolol—migraine	0.027	0.113	CbGbCtD
Propafenone—ADRB1—Propranolol—migraine	0.024	0.101	CbGbCtD
Propafenone—SCN5A—Topiramate—migraine	0.0228	0.0955	CbGbCtD
Propafenone—SCN5A—Verapamil—migraine	0.022	0.0921	CbGbCtD
Propafenone—KCNH2—Verapamil—migraine	0.0179	0.0748	CbGbCtD
Propafenone—Atomoxetine—Propranolol—migraine	0.0153	0.0595	CrCrCtD
Propafenone—CYP2C8—Amitriptyline—migraine	0.0083	0.0348	CbGbCtD
Propafenone—CYP2C8—Valproic Acid—migraine	0.00757	0.0317	CbGbCtD
Propafenone—CYP1A2—Propranolol—migraine	0.00743	0.0311	CbGbCtD
Propafenone—ABCB1—Timolol—migraine	0.00729	0.0305	CbGbCtD
Propafenone—CYP2D6—Timolol—migraine	0.00687	0.0288	CbGbCtD
Propafenone—CYP2C8—Verapamil—migraine	0.00659	0.0276	CbGbCtD
Propafenone—ABCB1—Propranolol—migraine	0.0065	0.0272	CbGbCtD
Propafenone—CYP1A2—Amitriptyline—migraine	0.00643	0.0269	CbGbCtD
Propafenone—CYP2D6—Propranolol—migraine	0.00612	0.0256	CbGbCtD
Propafenone—CYP1A2—Valproic Acid—migraine	0.00586	0.0245	CbGbCtD
Propafenone—CYP2C9—Amitriptyline—migraine	0.00579	0.0243	CbGbCtD
Propafenone—ABCB1—Amitriptyline—migraine	0.00562	0.0235	CbGbCtD
Propafenone—CYP2D6—Amitriptyline—migraine	0.0053	0.0222	CbGbCtD
Propafenone—CYP2C9—Valproic Acid—migraine	0.00528	0.0221	CbGbCtD
Propafenone—CYP1A2—Verapamil—migraine	0.0051	0.0214	CbGbCtD
Propafenone—CYP2C9—Verapamil—migraine	0.0046	0.0192	CbGbCtD
Propafenone—ABCB1—Verapamil—migraine	0.00446	0.0187	CbGbCtD
Propafenone—CYP2D6—Verapamil—migraine	0.0042	0.0176	CbGbCtD
Propafenone—CYP3A4—Propranolol—migraine	0.00389	0.0163	CbGbCtD
Propafenone—CYP3A4—Amitriptyline—migraine	0.00337	0.0141	CbGbCtD
Propafenone—CYP3A4—Valproic Acid—migraine	0.00307	0.0129	CbGbCtD
Propafenone—CYP3A4—Topiramate—migraine	0.00277	0.0116	CbGbCtD
Propafenone—CYP3A4—Verapamil—migraine	0.00267	0.0112	CbGbCtD
Propafenone—SCN5A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00086	0.0713	CbGpPWpGaD
Propafenone—SCN5A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.000731	0.0607	CbGpPWpGaD
Propafenone—ADRB1—Endothelin Pathways—RAMP1—migraine	0.00047	0.039	CbGpPWpGaD
Propafenone—ADRB1—Endothelin Pathways—CALCRL—migraine	0.00047	0.039	CbGpPWpGaD
Propafenone—KCNH2—Potassium Channels—KCNK18—migraine	0.000462	0.0383	CbGpPWpGaD
Propafenone—ADRB1—Monoamine GPCRs—HTR1D—migraine	0.000342	0.0283	CbGpPWpGaD
Propafenone—SCN5A—L1CAM interactions—SCN1A—migraine	0.00033	0.0274	CbGpPWpGaD
Propafenone—ADRB1—Monoamine GPCRs—HTR2B—migraine	0.000318	0.0264	CbGpPWpGaD
Propafenone—ADRB1—Amine ligand-binding receptors—HTR1D—migraine	0.000287	0.0238	CbGpPWpGaD
Propafenone—SCN5A—L1CAM interactions—SCN2A—migraine	0.000281	0.0233	CbGpPWpGaD
Propafenone—Alverine—HTR1A—migraine	0.000278	0.135	CrCbGaD
Propafenone—ADRB1—Amine ligand-binding receptors—HTR2B—migraine	0.000267	0.0222	CbGpPWpGaD
Propafenone—Bopindolol—HTR1B—migraine	0.000266	0.129	CrCbGaD
Propafenone—Benazepril—MTHFR—migraine	0.000229	0.111	CrCbGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000224	0.0186	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000217	0.018	CbGpPWpGaD
Propafenone—Quinapril—ACE—migraine	0.000215	0.104	CrCbGaD
Propafenone—Bopindolol—HTR1A—migraine	0.000211	0.102	CrCbGaD
Propafenone—ADRB1—Monoamine GPCRs—HTR1B—migraine	0.000207	0.0172	CbGpPWpGaD
Propafenone—KCNH2—Neuronal System—KCNK18—migraine	0.000202	0.0167	CbGpPWpGaD
Propafenone—ADRB1—Monoamine GPCRs—HTR1A—migraine	0.000199	0.0165	CbGpPWpGaD
Propafenone—ADRB1—Monoamine GPCRs—HTR2C—migraine	0.000192	0.016	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—HTR3A—migraine	0.00019	0.0158	CbGpPWpGaD
Propafenone—ADRB1—Endothelin Pathways—EDNRA—migraine	0.000187	0.0155	CbGpPWpGaD
Propafenone—Benazepril—ACE—migraine	0.000187	0.0907	CrCbGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—HTR3A—migraine	0.000184	0.0153	CbGpPWpGaD
Propafenone—ADRB1—Endothelin Pathways—CALCA—migraine	0.00018	0.0149	CbGpPWpGaD
Propafenone—Atomoxetine—HTR1D—migraine	0.000177	0.0861	CrCbGaD
Propafenone—ADRB1—Amine ligand-binding receptors—HTR1B—migraine	0.000174	0.0144	CbGpPWpGaD
Propafenone—ADRB1—Monoamine GPCRs—HTR7—migraine	0.000169	0.014	CbGpPWpGaD
Propafenone—ADRB1—Amine ligand-binding receptors—HTR1A—migraine	0.000168	0.0139	CbGpPWpGaD
Propafenone—ADRB1—G alpha (s) signalling events—RAMP1—migraine	0.000163	0.0135	CbGpPWpGaD
Propafenone—ADRB1—G alpha (s) signalling events—CALCRL—migraine	0.000163	0.0135	CbGpPWpGaD
Propafenone—ADRB1—Amine ligand-binding receptors—HTR2C—migraine	0.000162	0.0134	CbGpPWpGaD
Propafenone—ADRB1—Amine ligand-binding receptors—HTR7—migraine	0.000142	0.0118	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—SCN1A—migraine	0.000125	0.0103	CbGpPWpGaD
Propafenone—KCNH2—Hematopoietic Stem Cell Differentiation—FOS—migraine	0.000123	0.0102	CbGpPWpGaD
Propafenone—ADRB1—Monoamine GPCRs—HTR2A—migraine	0.000118	0.00979	CbGpPWpGaD
Propafenone—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000107	0.00885	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—SCN2A—migraine	0.000106	0.0088	CbGpPWpGaD
Propafenone—Atomoxetine—HTR1B—migraine	0.000105	0.0511	CrCbGaD
Propafenone—Propranolol—HTR1B—migraine	9.99e-05	0.0485	CrCbGaD
Propafenone—ADRB1—Amine ligand-binding receptors—HTR2A—migraine	9.93e-05	0.00823	CbGpPWpGaD
Propafenone—KCNH2—Neuronal System—CACNA1A—migraine	9.85e-05	0.00817	CbGpPWpGaD
Propafenone—CYP1A2—Estrogen Receptor Pathway—ESR1—migraine	9.16e-05	0.0076	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—HTR1A—migraine	9.05e-05	0.0075	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—TAC1—migraine	8.91e-05	0.00739	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—SCN1A—migraine	8.9e-05	0.00738	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—HTR1A—migraine	8.77e-05	0.00727	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—SLC6A4—migraine	8.74e-05	0.00725	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—TAC1—migraine	8.64e-05	0.00716	CbGpPWpGaD
Propafenone—Atomoxetine—HTR2C—migraine	8.58e-05	0.0416	CrCbGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—SLC6A4—migraine	8.47e-05	0.00703	CbGpPWpGaD
Propafenone—Propranolol—HTR1A—migraine	7.91e-05	0.0384	CrCbGaD
Propafenone—SCN5A—Developmental Biology—SCN2A—migraine	7.57e-05	0.00628	CbGpPWpGaD
Propafenone—Atomoxetine—SLC6A4—migraine	7.11e-05	0.0345	CrCbGaD
Propafenone—SCN5A—Developmental Biology—MEF2D—migraine	6.92e-05	0.00574	CbGpPWpGaD
Propafenone—ADRB1—G alpha (s) signalling events—NPS—migraine	6.81e-05	0.00565	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	6.6e-05	0.00547	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—BDNF—migraine	6.35e-05	0.00526	CbGpPWpGaD
Propafenone—ADRB1—G alpha (s) signalling events—CALCA—migraine	6.25e-05	0.00518	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—BDNF—migraine	6.15e-05	0.0051	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	6.13e-05	0.00509	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—CALCRL—migraine	5.92e-05	0.00491	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—RAMP1—migraine	5.92e-05	0.00491	CbGpPWpGaD
Propafenone—ADRB1—G alpha (s) signalling events—HTR7—migraine	5.85e-05	0.00485	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	5.65e-05	0.00469	CbGpPWpGaD
Propafenone—Atomoxetine—HTR2A—migraine	5.46e-05	0.0265	CrCbGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—HTR2A—migraine	5.36e-05	0.00445	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	5.25e-05	0.00436	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—HTR2A—migraine	5.2e-05	0.00431	CbGpPWpGaD
Propafenone—Hypersensitivity—Verapamil—migraine	4.52e-05	0.000549	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	4.51e-05	0.000547	CcSEcCtD
Propafenone—Epistaxis—Topiramate—migraine	4.49e-05	0.000545	CcSEcCtD
Propafenone—Alopecia—Gabapentin—migraine	4.49e-05	0.000544	CcSEcCtD
Propafenone—Discomfort—Valproic Acid—migraine	4.48e-05	0.000544	CcSEcCtD
Propafenone—Vision blurred—Timolol—migraine	4.47e-05	0.000543	CcSEcCtD
Propafenone—Mental disorder—Gabapentin—migraine	4.45e-05	0.00054	CcSEcCtD
Propafenone—Agranulocytosis—Topiramate—migraine	4.44e-05	0.000539	CcSEcCtD
Propafenone—Dry mouth—Valproic Acid—migraine	4.44e-05	0.000539	CcSEcCtD
Propafenone—Erythema—Gabapentin—migraine	4.42e-05	0.000536	CcSEcCtD
Propafenone—Malnutrition—Gabapentin—migraine	4.42e-05	0.000536	CcSEcCtD
Propafenone—Dizziness—Propranolol—migraine	4.41e-05	0.000535	CcSEcCtD
Propafenone—Asthenia—Verapamil—migraine	4.4e-05	0.000534	CcSEcCtD
Propafenone—Confusional state—Valproic Acid—migraine	4.39e-05	0.000532	CcSEcCtD
Propafenone—Flatulence—Gabapentin—migraine	4.35e-05	0.000528	CcSEcCtD
Propafenone—Oedema—Valproic Acid—migraine	4.35e-05	0.000528	CcSEcCtD
Propafenone—Bradycardia—Topiramate—migraine	4.35e-05	0.000528	CcSEcCtD
Propafenone—Pruritus—Verapamil—migraine	4.34e-05	0.000527	CcSEcCtD
Propafenone—Tension—Gabapentin—migraine	4.34e-05	0.000526	CcSEcCtD
Propafenone—Dysgeusia—Gabapentin—migraine	4.33e-05	0.000525	CcSEcCtD
Propafenone—Infection—Valproic Acid—migraine	4.32e-05	0.000525	CcSEcCtD
Propafenone—ADRB1—GPCR ligand binding—HTR1D—migraine	4.3e-05	0.00357	CbGpPWpGaD
Propafenone—Haemoglobin—Topiramate—migraine	4.29e-05	0.000521	CcSEcCtD
Propafenone—Nervousness—Gabapentin—migraine	4.29e-05	0.000521	CcSEcCtD
Propafenone—Rhinitis—Topiramate—migraine	4.28e-05	0.00052	CcSEcCtD
Propafenone—Haemorrhage—Topiramate—migraine	4.27e-05	0.000518	CcSEcCtD
Propafenone—Hepatitis—Topiramate—migraine	4.27e-05	0.000518	CcSEcCtD
Propafenone—Nervous system disorder—Valproic Acid—migraine	4.27e-05	0.000518	CcSEcCtD
Propafenone—Vertigo—Timolol—migraine	4.26e-05	0.000517	CcSEcCtD
Propafenone—Thrombocytopenia—Valproic Acid—migraine	4.26e-05	0.000517	CcSEcCtD
Propafenone—Syncope—Timolol—migraine	4.26e-05	0.000516	CcSEcCtD
Propafenone—Hypoaesthesia—Topiramate—migraine	4.25e-05	0.000516	CcSEcCtD
Propafenone—Muscle spasms—Gabapentin—migraine	4.25e-05	0.000516	CcSEcCtD
Propafenone—Tachycardia—Valproic Acid—migraine	4.25e-05	0.000515	CcSEcCtD
Propafenone—Vomiting—Propranolol—migraine	4.24e-05	0.000515	CcSEcCtD
Propafenone—Skin disorder—Valproic Acid—migraine	4.23e-05	0.000513	CcSEcCtD
Propafenone—Urinary tract disorder—Topiramate—migraine	4.22e-05	0.000512	CcSEcCtD
Propafenone—Hyperhidrosis—Valproic Acid—migraine	4.21e-05	0.00051	CcSEcCtD
Propafenone—Rash—Propranolol—migraine	4.21e-05	0.00051	CcSEcCtD
Propafenone—Dermatitis—Propranolol—migraine	4.2e-05	0.00051	CcSEcCtD
Propafenone—Diarrhoea—Verapamil—migraine	4.2e-05	0.00051	CcSEcCtD
Propafenone—Connective tissue disorder—Topiramate—migraine	4.2e-05	0.000509	CcSEcCtD
Propafenone—Palpitations—Timolol—migraine	4.19e-05	0.000509	CcSEcCtD
Propafenone—Urethral disorder—Topiramate—migraine	4.19e-05	0.000508	CcSEcCtD
Propafenone—Loss of consciousness—Timolol—migraine	4.17e-05	0.000506	CcSEcCtD
Propafenone—Vision blurred—Gabapentin—migraine	4.16e-05	0.000505	CcSEcCtD
Propafenone—Anorexia—Valproic Acid—migraine	4.15e-05	0.000503	CcSEcCtD
Propafenone—Cough—Timolol—migraine	4.14e-05	0.000503	CcSEcCtD
Propafenone—Tremor—Gabapentin—migraine	4.14e-05	0.000502	CcSEcCtD
Propafenone—Visual impairment—Topiramate—migraine	4.12e-05	0.0005	CcSEcCtD
Propafenone—Ill-defined disorder—Gabapentin—migraine	4.1e-05	0.000498	CcSEcCtD
Propafenone—Hypertension—Timolol—migraine	4.1e-05	0.000497	CcSEcCtD
Propafenone—Anaemia—Gabapentin—migraine	4.08e-05	0.000496	CcSEcCtD
Propafenone—Hypotension—Valproic Acid—migraine	4.07e-05	0.000493	CcSEcCtD
Propafenone—Dizziness—Verapamil—migraine	4.06e-05	0.000492	CcSEcCtD
Propafenone—Myalgia—Timolol—migraine	4.04e-05	0.00049	CcSEcCtD
Propafenone—Chest pain—Timolol—migraine	4.04e-05	0.00049	CcSEcCtD
Propafenone—Anxiety—Timolol—migraine	4.03e-05	0.000489	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	4.01e-05	0.000487	CcSEcCtD
Propafenone—ADRB1—GPCR ligand binding—HTR2B—migraine	4e-05	0.00332	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	4e-05	0.00331	CbGpPWpGaD
Propafenone—Discomfort—Timolol—migraine	3.99e-05	0.000484	CcSEcCtD
Propafenone—Eye disorder—Topiramate—migraine	3.99e-05	0.000484	CcSEcCtD
Propafenone—Malaise—Gabapentin—migraine	3.99e-05	0.000484	CcSEcCtD
Propafenone—Tinnitus—Topiramate—migraine	3.98e-05	0.000483	CcSEcCtD
Propafenone—Vertigo—Gabapentin—migraine	3.97e-05	0.000482	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Valproic Acid—migraine	3.96e-05	0.000481	CcSEcCtD
Propafenone—Cardiac disorder—Topiramate—migraine	3.96e-05	0.000481	CcSEcCtD
Propafenone—Flushing—Topiramate—migraine	3.96e-05	0.000481	CcSEcCtD
Propafenone—Syncope—Gabapentin—migraine	3.96e-05	0.000481	CcSEcCtD
Propafenone—Nausea—Propranolol—migraine	3.96e-05	0.000481	CcSEcCtD
Propafenone—Leukopenia—Gabapentin—migraine	3.96e-05	0.00048	CcSEcCtD
Propafenone—Dry mouth—Timolol—migraine	3.95e-05	0.00048	CcSEcCtD
Propafenone—Insomnia—Valproic Acid—migraine	3.94e-05	0.000478	CcSEcCtD
Propafenone—Paraesthesia—Valproic Acid—migraine	3.91e-05	0.000474	CcSEcCtD
Propafenone—Palpitations—Gabapentin—migraine	3.91e-05	0.000474	CcSEcCtD
Propafenone—Confusional state—Timolol—migraine	3.91e-05	0.000474	CcSEcCtD
Propafenone—Vomiting—Verapamil—migraine	3.9e-05	0.000473	CcSEcCtD
Propafenone—Loss of consciousness—Gabapentin—migraine	3.88e-05	0.000471	CcSEcCtD
Propafenone—Dyspnoea—Valproic Acid—migraine	3.88e-05	0.000471	CcSEcCtD
Propafenone—Angiopathy—Topiramate—migraine	3.88e-05	0.00047	CcSEcCtD
Propafenone—Oedema—Timolol—migraine	3.87e-05	0.00047	CcSEcCtD
Propafenone—Rash—Verapamil—migraine	3.87e-05	0.00047	CcSEcCtD
Propafenone—Somnolence—Valproic Acid—migraine	3.87e-05	0.000469	CcSEcCtD
Propafenone—Dermatitis—Verapamil—migraine	3.87e-05	0.000469	CcSEcCtD
Propafenone—Immune system disorder—Topiramate—migraine	3.86e-05	0.000468	CcSEcCtD
Propafenone—Cough—Gabapentin—migraine	3.86e-05	0.000468	CcSEcCtD
Propafenone—Mediastinal disorder—Topiramate—migraine	3.85e-05	0.000467	CcSEcCtD
Propafenone—Infection—Timolol—migraine	3.85e-05	0.000467	CcSEcCtD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	3.85e-05	0.00319	CbGpPWpGaD
Propafenone—Headache—Verapamil—migraine	3.84e-05	0.000467	CcSEcCtD
Propafenone—Dyspepsia—Valproic Acid—migraine	3.83e-05	0.000465	CcSEcCtD
Propafenone—Convulsion—Gabapentin—migraine	3.83e-05	0.000465	CcSEcCtD
Propafenone—Hypertension—Gabapentin—migraine	3.82e-05	0.000463	CcSEcCtD
Propafenone—Shock—Timolol—migraine	3.81e-05	0.000462	CcSEcCtD
Propafenone—Nervous system disorder—Timolol—migraine	3.8e-05	0.000461	CcSEcCtD
Propafenone—Decreased appetite—Valproic Acid—migraine	3.78e-05	0.000459	CcSEcCtD
Propafenone—Alopecia—Topiramate—migraine	3.77e-05	0.000458	CcSEcCtD
Propafenone—Myalgia—Gabapentin—migraine	3.76e-05	0.000457	CcSEcCtD
Propafenone—Chest pain—Gabapentin—migraine	3.76e-05	0.000457	CcSEcCtD
Propafenone—Skin disorder—Timolol—migraine	3.76e-05	0.000457	CcSEcCtD
Propafenone—Gastrointestinal disorder—Valproic Acid—migraine	3.76e-05	0.000456	CcSEcCtD
Propafenone—Fatigue—Valproic Acid—migraine	3.75e-05	0.000455	CcSEcCtD
Propafenone—Anxiety—Gabapentin—migraine	3.75e-05	0.000455	CcSEcCtD
Propafenone—Hyperhidrosis—Timolol—migraine	3.74e-05	0.000454	CcSEcCtD
Propafenone—Mental disorder—Topiramate—migraine	3.74e-05	0.000454	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	3.74e-05	0.000453	CcSEcCtD
Propafenone—Pain—Valproic Acid—migraine	3.72e-05	0.000452	CcSEcCtD
Propafenone—Constipation—Valproic Acid—migraine	3.72e-05	0.000452	CcSEcCtD
Propafenone—Erythema—Topiramate—migraine	3.72e-05	0.000451	CcSEcCtD
Propafenone—Malnutrition—Topiramate—migraine	3.72e-05	0.000451	CcSEcCtD
Propafenone—Discomfort—Gabapentin—migraine	3.72e-05	0.000451	CcSEcCtD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	3.71e-05	0.00308	CbGpPWpGaD
Propafenone—Anorexia—Timolol—migraine	3.69e-05	0.000448	CcSEcCtD
Propafenone—Dry mouth—Gabapentin—migraine	3.68e-05	0.000447	CcSEcCtD
Propafenone—Flatulence—Topiramate—migraine	3.66e-05	0.000445	CcSEcCtD
Propafenone—Tension—Topiramate—migraine	3.65e-05	0.000443	CcSEcCtD
Propafenone—Nausea—Verapamil—migraine	3.64e-05	0.000442	CcSEcCtD
Propafenone—Dysgeusia—Topiramate—migraine	3.64e-05	0.000442	CcSEcCtD
Propafenone—Confusional state—Gabapentin—migraine	3.64e-05	0.000441	CcSEcCtD
Propafenone—Hypotension—Timolol—migraine	3.62e-05	0.000439	CcSEcCtD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	3.61e-05	0.003	CbGpPWpGaD
Propafenone—Nervousness—Topiramate—migraine	3.61e-05	0.000438	CcSEcCtD
Propafenone—Oedema—Gabapentin—migraine	3.61e-05	0.000438	CcSEcCtD
Propafenone—Feeling abnormal—Valproic Acid—migraine	3.59e-05	0.000435	CcSEcCtD
Propafenone—Infection—Gabapentin—migraine	3.58e-05	0.000435	CcSEcCtD
Propafenone—Muscle spasms—Topiramate—migraine	3.57e-05	0.000434	CcSEcCtD
Propafenone—Gastrointestinal pain—Valproic Acid—migraine	3.56e-05	0.000432	CcSEcCtD
Propafenone—Shock—Gabapentin—migraine	3.55e-05	0.000431	CcSEcCtD
Propafenone—Nervous system disorder—Gabapentin—migraine	3.54e-05	0.000429	CcSEcCtD
Propafenone—Thrombocytopenia—Gabapentin—migraine	3.53e-05	0.000429	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Timolol—migraine	3.53e-05	0.000428	CcSEcCtD
Propafenone—Tachycardia—Gabapentin—migraine	3.52e-05	0.000427	CcSEcCtD
Propafenone—Vision blurred—Topiramate—migraine	3.5e-05	0.000425	CcSEcCtD
Propafenone—Skin disorder—Gabapentin—migraine	3.5e-05	0.000425	CcSEcCtD
Propafenone—Insomnia—Timolol—migraine	3.5e-05	0.000425	CcSEcCtD
Propafenone—Hyperhidrosis—Gabapentin—migraine	3.49e-05	0.000423	CcSEcCtD
Propafenone—Tremor—Topiramate—migraine	3.48e-05	0.000423	CcSEcCtD
Propafenone—Paraesthesia—Timolol—migraine	3.48e-05	0.000422	CcSEcCtD
Propafenone—Urticaria—Valproic Acid—migraine	3.46e-05	0.000419	CcSEcCtD
Propafenone—Dyspnoea—Timolol—migraine	3.45e-05	0.000419	CcSEcCtD
Propafenone—Ill-defined disorder—Topiramate—migraine	3.45e-05	0.000419	CcSEcCtD
Propafenone—Somnolence—Timolol—migraine	3.44e-05	0.000418	CcSEcCtD
Propafenone—Body temperature increased—Valproic Acid—migraine	3.44e-05	0.000417	CcSEcCtD
Propafenone—Abdominal pain—Valproic Acid—migraine	3.44e-05	0.000417	CcSEcCtD
Propafenone—Anorexia—Gabapentin—migraine	3.44e-05	0.000417	CcSEcCtD
Propafenone—Anaemia—Topiramate—migraine	3.44e-05	0.000417	CcSEcCtD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	3.42e-05	0.00284	CbGpPWpGaD
Propafenone—Dyspepsia—Timolol—migraine	3.41e-05	0.000414	CcSEcCtD
Propafenone—Hypotension—Gabapentin—migraine	3.37e-05	0.000409	CcSEcCtD
Propafenone—Decreased appetite—Timolol—migraine	3.37e-05	0.000409	CcSEcCtD
Propafenone—Malaise—Topiramate—migraine	3.35e-05	0.000407	CcSEcCtD
Propafenone—ADRB1—GPCR downstream signaling—RAMP1—migraine	3.35e-05	0.00278	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CALCRL—migraine	3.35e-05	0.00278	CbGpPWpGaD
Propafenone—Gastrointestinal disorder—Timolol—migraine	3.34e-05	0.000406	CcSEcCtD
Propafenone—Vertigo—Topiramate—migraine	3.34e-05	0.000405	CcSEcCtD
Propafenone—Fatigue—Timolol—migraine	3.34e-05	0.000405	CcSEcCtD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	3.33e-05	0.00277	CbGpPWpGaD
Propafenone—Syncope—Topiramate—migraine	3.33e-05	0.000405	CcSEcCtD
Propafenone—Leukopenia—Topiramate—migraine	3.33e-05	0.000404	CcSEcCtD
Propafenone—Pain—Timolol—migraine	3.31e-05	0.000402	CcSEcCtD
Propafenone—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	3.3e-05	0.00273	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	3.3e-05	0.00273	CbGpPWpGaD
Propafenone—Musculoskeletal discomfort—Gabapentin—migraine	3.29e-05	0.000399	CcSEcCtD
Propafenone—Palpitations—Topiramate—migraine	3.29e-05	0.000399	CcSEcCtD
Propafenone—Loss of consciousness—Topiramate—migraine	3.27e-05	0.000397	CcSEcCtD
Propafenone—Insomnia—Gabapentin—migraine	3.26e-05	0.000396	CcSEcCtD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	3.25e-05	0.0027	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	3.25e-05	0.00269	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	3.25e-05	0.00269	CbGpPWpGaD
Propafenone—Cough—Topiramate—migraine	3.24e-05	0.000394	CcSEcCtD
Propafenone—Paraesthesia—Gabapentin—migraine	3.24e-05	0.000393	CcSEcCtD
Propafenone—Convulsion—Topiramate—migraine	3.22e-05	0.000391	CcSEcCtD
Propafenone—Dyspnoea—Gabapentin—migraine	3.22e-05	0.00039	CcSEcCtD
Propafenone—Hypertension—Topiramate—migraine	3.21e-05	0.00039	CcSEcCtD
Propafenone—Somnolence—Gabapentin—migraine	3.21e-05	0.000389	CcSEcCtD
Propafenone—Hypersensitivity—Valproic Acid—migraine	3.21e-05	0.000389	CcSEcCtD
Propafenone—Feeling abnormal—Timolol—migraine	3.19e-05	0.000387	CcSEcCtD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	3.18e-05	0.00264	CbGpPWpGaD
Propafenone—Dyspepsia—Gabapentin—migraine	3.17e-05	0.000385	CcSEcCtD
Propafenone—Gastrointestinal pain—Timolol—migraine	3.17e-05	0.000384	CcSEcCtD
Propafenone—Myalgia—Topiramate—migraine	3.17e-05	0.000384	CcSEcCtD
Propafenone—Chest pain—Topiramate—migraine	3.17e-05	0.000384	CcSEcCtD
Propafenone—Anxiety—Topiramate—migraine	3.15e-05	0.000383	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	3.14e-05	0.000381	CcSEcCtD
Propafenone—Decreased appetite—Gabapentin—migraine	3.14e-05	0.00038	CcSEcCtD
Propafenone—Discomfort—Topiramate—migraine	3.13e-05	0.00038	CcSEcCtD
Propafenone—Asthenia—Valproic Acid—migraine	3.12e-05	0.000379	CcSEcCtD
Propafenone—Gastrointestinal disorder—Gabapentin—migraine	3.11e-05	0.000378	CcSEcCtD
Propafenone—Fatigue—Gabapentin—migraine	3.11e-05	0.000377	CcSEcCtD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	3.1e-05	0.00257	CbGpPWpGaD
Propafenone—Dry mouth—Topiramate—migraine	3.1e-05	0.000376	CcSEcCtD
Propafenone—Pain—Gabapentin—migraine	3.08e-05	0.000374	CcSEcCtD
Propafenone—Constipation—Gabapentin—migraine	3.08e-05	0.000374	CcSEcCtD
Propafenone—Pruritus—Valproic Acid—migraine	3.08e-05	0.000374	CcSEcCtD
Propafenone—Urticaria—Timolol—migraine	3.08e-05	0.000373	CcSEcCtD
Propafenone—Body temperature increased—Timolol—migraine	3.06e-05	0.000372	CcSEcCtD
Propafenone—Abdominal pain—Timolol—migraine	3.06e-05	0.000372	CcSEcCtD
Propafenone—Confusional state—Topiramate—migraine	3.06e-05	0.000371	CcSEcCtD
Propafenone—ADRB1—Signaling by GPCR—RAMP1—migraine	3.04e-05	0.00252	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CALCRL—migraine	3.04e-05	0.00252	CbGpPWpGaD
Propafenone—Oedema—Topiramate—migraine	3.03e-05	0.000368	CcSEcCtD
Propafenone—Infection—Topiramate—migraine	3.01e-05	0.000366	CcSEcCtD
Propafenone—Shock—Topiramate—migraine	2.99e-05	0.000362	CcSEcCtD
Propafenone—Diarrhoea—Valproic Acid—migraine	2.98e-05	0.000361	CcSEcCtD
Propafenone—Nervous system disorder—Topiramate—migraine	2.98e-05	0.000361	CcSEcCtD
Propafenone—Feeling abnormal—Gabapentin—migraine	2.97e-05	0.000361	CcSEcCtD
Propafenone—Thrombocytopenia—Topiramate—migraine	2.97e-05	0.000361	CcSEcCtD
Propafenone—Tachycardia—Topiramate—migraine	2.96e-05	0.000359	CcSEcCtD
Propafenone—Gastrointestinal pain—Gabapentin—migraine	2.95e-05	0.000358	CcSEcCtD
Propafenone—Skin disorder—Topiramate—migraine	2.95e-05	0.000358	CcSEcCtD
Propafenone—Hyperhidrosis—Topiramate—migraine	2.93e-05	0.000356	CcSEcCtD
Propafenone—Anorexia—Topiramate—migraine	2.89e-05	0.000351	CcSEcCtD
Propafenone—Dizziness—Valproic Acid—migraine	2.88e-05	0.000349	CcSEcCtD
Propafenone—Urticaria—Gabapentin—migraine	2.87e-05	0.000348	CcSEcCtD
Propafenone—Hypersensitivity—Timolol—migraine	2.85e-05	0.000346	CcSEcCtD
Propafenone—Body temperature increased—Gabapentin—migraine	2.85e-05	0.000346	CcSEcCtD
Propafenone—Abdominal pain—Gabapentin—migraine	2.85e-05	0.000346	CcSEcCtD
Propafenone—Hypotension—Topiramate—migraine	2.84e-05	0.000344	CcSEcCtD
Propafenone—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	2.82e-05	0.00234	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	2.79e-05	0.00231	CbGpPWpGaD
Propafenone—Asthenia—Timolol—migraine	2.78e-05	0.000337	CcSEcCtD
Propafenone—Vomiting—Valproic Acid—migraine	2.77e-05	0.000336	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Topiramate—migraine	2.76e-05	0.000336	CcSEcCtD
Propafenone—Insomnia—Topiramate—migraine	2.74e-05	0.000333	CcSEcCtD
Propafenone—Rash—Valproic Acid—migraine	2.74e-05	0.000333	CcSEcCtD
Propafenone—Dermatitis—Valproic Acid—migraine	2.74e-05	0.000333	CcSEcCtD
Propafenone—Pruritus—Timolol—migraine	2.74e-05	0.000333	CcSEcCtD
Propafenone—Headache—Valproic Acid—migraine	2.73e-05	0.000331	CcSEcCtD
Propafenone—Paraesthesia—Topiramate—migraine	2.72e-05	0.000331	CcSEcCtD
Propafenone—Dyspnoea—Topiramate—migraine	2.71e-05	0.000328	CcSEcCtD
Propafenone—Somnolence—Topiramate—migraine	2.7e-05	0.000327	CcSEcCtD
Propafenone—Dyspepsia—Topiramate—migraine	2.67e-05	0.000324	CcSEcCtD
Propafenone—Hypersensitivity—Gabapentin—migraine	2.66e-05	0.000322	CcSEcCtD
Propafenone—Diarrhoea—Timolol—migraine	2.65e-05	0.000322	CcSEcCtD
Propafenone—Decreased appetite—Topiramate—migraine	2.64e-05	0.00032	CcSEcCtD
Propafenone—Gastrointestinal disorder—Topiramate—migraine	2.62e-05	0.000318	CcSEcCtD
Propafenone—Fatigue—Topiramate—migraine	2.62e-05	0.000317	CcSEcCtD
Propafenone—ADRB1—GPCR ligand binding—HTR1B—migraine	2.61e-05	0.00216	CbGpPWpGaD
Propafenone—Constipation—Topiramate—migraine	2.59e-05	0.000315	CcSEcCtD
Propafenone—Pain—Topiramate—migraine	2.59e-05	0.000315	CcSEcCtD
Propafenone—Asthenia—Gabapentin—migraine	2.59e-05	0.000314	CcSEcCtD
Propafenone—Nausea—Valproic Acid—migraine	2.58e-05	0.000314	CcSEcCtD
Propafenone—Dizziness—Timolol—migraine	2.56e-05	0.000311	CcSEcCtD
Propafenone—Pruritus—Gabapentin—migraine	2.55e-05	0.00031	CcSEcCtD
Propafenone—ADRB1—GPCR ligand binding—HTR1A—migraine	2.51e-05	0.00208	CbGpPWpGaD
Propafenone—Feeling abnormal—Topiramate—migraine	2.5e-05	0.000303	CcSEcCtD
Propafenone—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	2.5e-05	0.00207	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	2.5e-05	0.00207	CbGpPWpGaD
Propafenone—Gastrointestinal pain—Topiramate—migraine	2.48e-05	0.000301	CcSEcCtD
Propafenone—ADRB1—GPCR ligand binding—NPS—migraine	2.47e-05	0.00205	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—TAC1—migraine	2.47e-05	0.00205	CbGpPWpGaD
Propafenone—Diarrhoea—Gabapentin—migraine	2.47e-05	0.000299	CcSEcCtD
Propafenone—Vomiting—Timolol—migraine	2.46e-05	0.000299	CcSEcCtD
Propafenone—Rash—Timolol—migraine	2.44e-05	0.000296	CcSEcCtD
Propafenone—Dermatitis—Timolol—migraine	2.44e-05	0.000296	CcSEcCtD
Propafenone—ADRB1—GPCR downstream signaling—HTR1D—migraine	2.43e-05	0.00202	CbGpPWpGaD
Propafenone—Headache—Timolol—migraine	2.43e-05	0.000294	CcSEcCtD
Propafenone—ADRB1—GPCR ligand binding—HTR2C—migraine	2.42e-05	0.00201	CbGpPWpGaD
Propafenone—Urticaria—Topiramate—migraine	2.41e-05	0.000293	CcSEcCtD
Propafenone—Abdominal pain—Topiramate—migraine	2.4e-05	0.000291	CcSEcCtD
Propafenone—Body temperature increased—Topiramate—migraine	2.4e-05	0.000291	CcSEcCtD
Propafenone—Dizziness—Gabapentin—migraine	2.39e-05	0.000289	CcSEcCtD
Propafenone—ADRB1—GPCR ligand binding—EDNRA—migraine	2.36e-05	0.00196	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—TNF—migraine	2.31e-05	0.00191	CbGpPWpGaD
Propafenone—Nausea—Timolol—migraine	2.3e-05	0.000279	CcSEcCtD
Propafenone—Vomiting—Gabapentin—migraine	2.29e-05	0.000278	CcSEcCtD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	2.28e-05	0.00189	CbGpPWpGaD
Propafenone—Rash—Gabapentin—migraine	2.27e-05	0.000276	CcSEcCtD
Propafenone—Dermatitis—Gabapentin—migraine	2.27e-05	0.000276	CcSEcCtD
Propafenone—ADRB1—GPCR ligand binding—CALCA—migraine	2.27e-05	0.00188	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—HTR2B—migraine	2.26e-05	0.00187	CbGpPWpGaD
Propafenone—Headache—Gabapentin—migraine	2.26e-05	0.000274	CcSEcCtD
Propafenone—Hypersensitivity—Topiramate—migraine	2.24e-05	0.000271	CcSEcCtD
Propafenone—KCNH2—SIDS Susceptibility Pathways—TNF—migraine	2.23e-05	0.00185	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—HTR1D—migraine	2.21e-05	0.00183	CbGpPWpGaD
Propafenone—Asthenia—Topiramate—migraine	2.18e-05	0.000264	CcSEcCtD
Propafenone—Pruritus—Topiramate—migraine	2.15e-05	0.000261	CcSEcCtD
Propafenone—Nausea—Gabapentin—migraine	2.14e-05	0.00026	CcSEcCtD
Propafenone—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	2.12e-05	0.00176	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—HTR7—migraine	2.12e-05	0.00176	CbGpPWpGaD
Propafenone—Diarrhoea—Topiramate—migraine	2.08e-05	0.000252	CcSEcCtD
Propafenone—ADRB1—Signaling by GPCR—HTR2B—migraine	2.05e-05	0.0017	CbGpPWpGaD
Propafenone—Dizziness—Topiramate—migraine	2.01e-05	0.000244	CcSEcCtD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	1.95e-05	0.00162	CbGpPWpGaD
Propafenone—Vomiting—Topiramate—migraine	1.93e-05	0.000234	CcSEcCtD
Propafenone—Rash—Topiramate—migraine	1.91e-05	0.000232	CcSEcCtD
Propafenone—Dermatitis—Topiramate—migraine	1.91e-05	0.000232	CcSEcCtD
Propafenone—Headache—Topiramate—migraine	1.9e-05	0.000231	CcSEcCtD
Propafenone—Nausea—Topiramate—migraine	1.8e-05	0.000219	CcSEcCtD
Propafenone—ADRB1—Signaling Pathways—RAMP1—migraine	1.8e-05	0.00149	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CALCRL—migraine	1.8e-05	0.00149	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	1.78e-05	0.00148	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	1.62e-05	0.00134	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	1.62e-05	0.00134	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—HTR2A—migraine	1.49e-05	0.00123	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—HTR1B—migraine	1.47e-05	0.00122	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—HTR1A—migraine	1.42e-05	0.00118	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—TAC1—migraine	1.4e-05	0.00116	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—NPS—migraine	1.4e-05	0.00116	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—HTR2C—migraine	1.37e-05	0.00114	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—HTR1B—migraine	1.34e-05	0.00111	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	1.34e-05	0.00111	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—EDNRA—migraine	1.33e-05	0.00111	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—TNF—migraine	1.31e-05	0.00109	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HTR1D—migraine	1.3e-05	0.00108	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—HTR1A—migraine	1.29e-05	0.00107	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CALCA—migraine	1.28e-05	0.00106	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—NPS—migraine	1.27e-05	0.00105	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—TAC1—migraine	1.27e-05	0.00105	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—HTR2C—migraine	1.24e-05	0.00103	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HTR2B—migraine	1.21e-05	0.00101	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—EDNRA—migraine	1.21e-05	0.001	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—HTR7—migraine	1.2e-05	0.000995	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CALCA—migraine	1.16e-05	0.000966	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—HTR7—migraine	1.09e-05	0.000903	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—LRP1—migraine	1.07e-05	0.000885	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CACNA1A—migraine	9.71e-06	0.000805	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—TNF—migraine	9.17e-06	0.00076	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CACNA1A—migraine	8.46e-06	0.000702	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—HTR2A—migraine	8.4e-06	0.000697	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NOTCH4—migraine	8.19e-06	0.000679	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CACNA1A—migraine	7.97e-06	0.000661	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HTR1B—migraine	7.9e-06	0.000655	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CACNA1A—migraine	7.9e-06	0.000655	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—HTR2A—migraine	7.63e-06	0.000633	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HTR1A—migraine	7.61e-06	0.000631	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TAC1—migraine	7.49e-06	0.000621	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NPS—migraine	7.49e-06	0.000621	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PGR—migraine	7.49e-06	0.000621	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HTR2C—migraine	7.35e-06	0.000609	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EDNRA—migraine	7.15e-06	0.000593	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NOTCH3—migraine	6.97e-06	0.000578	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CALCA—migraine	6.88e-06	0.000571	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CACNA1A—migraine	6.75e-06	0.00056	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	6.48e-06	0.000537	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HTR7—migraine	6.44e-06	0.000534	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TGFBR2—migraine	5.54e-06	0.00046	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CACNA1A—migraine	5.21e-06	0.000432	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HTR2A—migraine	4.51e-06	0.000374	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ESR1—migraine	4e-06	0.000332	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—MTHFR—migraine	3.21e-06	0.000266	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—MTHFR—migraine	2.8e-06	0.000232	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—MTHFR—migraine	2.64e-06	0.000219	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—MTHFR—migraine	2.61e-06	0.000217	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—MTHFR—migraine	2.23e-06	0.000185	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MTHFR—migraine	1.72e-06	0.000143	CbGpPWpGaD
